# 510(k) Summary - ISE Indirect Na, K, CI for Gen.2

# Introduction

According to the requirements of 21 CFR 807.92, the following information provides sufficient detail to understand the basis for a determination of substantial equivalence

# Submitter name, address, contact

Roche Diagnostics 9115 Hague Rd Indianapolis IN 46250 (317) 521-3723

Contact person: Kerwin Kaufman

Date prepared: November 11, 2005

# Device Name

Proprietary name: ISE Indirect Na, K, Cl for Gen.2

Common names:

Sodium Test System Potassium Test System Chloride Test System

Classification names:

Ion-Specific Electrode Sodium Ion-Specific Electrode Potassium Ion-Specific Electrode Chloride

# 510(k) Summary - ISE Indirect Na, K, CI for Gen.2, Continued

# Device Description

An lon-Selective Electrode (ISE) makes use of the unique properties of certain membrane materials to develop an electrical potential (electromotive force, EMF) for the measurements of ions in solution. The electrode has a selective membrane in contact with both the test solution and an internal filling solution. The internal filling solution contains the test ion at a fixed concentration. Because of the particular nature of the membrane, the test ions will closely associate with the membrane on each side. The membrane EMF is determined by the difference in concentration of the test ion in the test solution and the internal filling solution. The EMF develops according to the Nernst equation for a specific ion is solution (see package insert for further explanation).

The complete measurement system for a particular ion includes the ISE, a reference electrode and electronic circuits to measure and process the EMF to give the test ion concentration. The sodium and potassium electrodes are based on neutral carriers and the chloride electrode is based on an ion exchanger.

# Intended use / Indications for use

The ISE module of the Roche / Hitachi systems is intended for the quantitative determination of sodium, potassium, and chloride in serum, plasma, or urine using ion-selective electrodes.

Sodium measurements are used in the diagnosis and treatment of aldosteronism (excessive secretion of the hormone aldosterone), diabetes insipidus (chronic excretion of large amounts of dilute urine, accompanied by extreme thirst), adrenal hypertension, Addison's disease (caused by destruction of the adrenal glands), dehydration, inappropriate antidiuretic hormone secretion, or other diseases involving electrolyte imbalance. Potassium measurements are used to monitor electrolyte balance in the diagnosis and treatment of disease conditions characterized by low or high blood potassium levels. Chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders such as cystic fibrosis and diabetic acidosis.

# Predicate Device

# 510(k) Summary - ISE Indirect Na, K, Cl for Gen.2, Continued

The table below indicates the similarities between the modified ISE Indirect Na, K, Cl for Gen.2 device and its predicate device (original ISE Na, K, Cl, K953239).

Substantial equivalency - Similarities   

<table><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Predicate device: originalISE Na, K, Cl (K953239)</td><td rowspan=1 colspan=1>Modified device: ISE Indirect Na,K, Cl for Gen.2</td></tr><tr><td rowspan=1 colspan=3>General</td></tr><tr><td rowspan=1 colspan=1>Instruments</td><td rowspan=1 colspan=1>Roche Hitachi automated analyzerfamily</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Intended Use/Indications forUse</td><td rowspan=1 colspan=1>For the quantitative determination ofsodium, potassium, and chloride inserum, plasma, and urine.Sodium measurements are used inthe diagnosis and treatment ofaldosteronism (excessive secretionof the hormone aldosterone),diabetes insipidus (chronic excretionof large amounts of dilute urine,accompanied by extreme thirst),adrenal hypertension, Addison&#x27;sdisease (caused by destruction of theadrenal glands), dehydration,inappropriate antidiuretic hormonesecretion, or other diseasesinvolving electrolyte imbalance.Potassium measurements are used tomonitor electrolyte balance in thediagnosis and treatment of diseaseconditions characterized by low orhigh blood potassium levels.Chloride measurements are used inthe diagnosis and treatment ofelectrolyte and metabolic disorderssuch as cystic fibrosis and diabeticacidosis.</td><td rowspan=1 colspan=1>The ISE module of the Roche / Hitachisystems is intended for the quantitativedetermination of sodium, potassium,and chloride in serum, plasma, orurine using ion-selective electrodes.Sodium measurements are used in thediagnosis and treatment ofaldosteronism (excessive secretion ofthe hormone aldosterone), diabetesinsipidus (chronic excretion of largeamounts of dilute urine, accompaniedby extreme thirst), adrenalhypertension, Addison&#x27;s disease(caused by destruction of the adrenalglands), dehydration, inappropriateantidiuretic hormone secretion, orother diseases involving electrolyteimbalance. Potassium measurementsare used to monitor electrolyte balancein the diagnosis and treatment ofdisease conditions characterized bylow or high blood potassium levels.Chloride measurements are used in thediagnosis and treatment of electrolyteand metabolic disorders such as cysticfibrosis and diabetic acidosis.</td></tr></table>

# 510(k) Summary - ISE Indirect Na, K, CI for Gen.2, Continued

<table><tr><td>Feature</td><td>Predicate device: original ISE Na, K, Cl (K953239)</td><td>Modified device: ISE Indirect Na, K, Cl for Gen.2</td></tr><tr><td colspan="3">Test principle</td></tr><tr><td>Sample types</td><td>Serum, Plasma (Lithium heparin) or Urine</td><td>Same</td></tr><tr><td>Determination of Sodium, Potassium and Chloride</td><td>An Ion-Selective Electrode (ISE) makes use of the unique properties of certain membrane materials to develop an electrical potential (electromotive force, EMF) for the measurements of ions in solution. The electrode has a selective membrane in contact with both the test solution and an internal filling solution. The internal filling solution contains the test ion at a fixed concentration. Because of the particular nature of the membrane, the test ions will closely associate with the membrane on each side. The membrane EMF is determined by the difference in concentration of the test ion in the test solution and the internal filling solution. The EMF develops according to the Nernst equation for a specific ion is solution (see package insert for further explanation). The complete measurement system for a particular ion includes the ISE, a reference electrode and electronic circuits to measure and process the EMF to give the test ion concentration. The sodium and potassium electrodes are based on neutral carriers and the chloride electrode is based on an ion exchanger.</td><td>Same</td></tr></table>

# 510(k) Summary - ISE Indirect Na, K, Cl for Gen.2, Continued

<table><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Predicate device: originalISE Na, K, Cl (K953239)</td><td rowspan=1 colspan=1>Modified device: ISE Indirect Na,K, Cl for Gen.2</td></tr><tr><td rowspan=1 colspan=3>Electrode / Reagent information</td></tr><tr><td rowspan=1 colspan=1>Ion-SpecificElectrodes</td><td rowspan=1 colspan=1>Sodium Electrode/ CartridgePotassium Electrode/ CartridgeChloride Electrode/ CartridgeReference Electrode/ Cartridge</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>ElectrodeOnboardStability</td><td rowspan=1 colspan=1>Sodium, Potassium and ChlorideElectrodes, 2 months or 9000 testsReference Electrode, at least 6months</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Calibrators S1,S2 for two-pointcalibration</td><td rowspan=1 colspan=1>S1: ISE Standard LowS2: ISE Standard High</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>AuxiliaryReagents</td><td rowspan=1 colspan=1>ISE 1 N potassium chloride(Reference Electrolyte)</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=3>Performance characteristics</td></tr><tr><td rowspan=1 colspan=1>ReportableRange</td><td rowspan=1 colspan=1>Serum/Plasma:Na*: 80 - 180 mmol/LK*: 1.5 - 10 mmol/LCl: 60-140 mmol/LUrine:Na*: 10 - 250 mmol/LK*: 1 - 100 mmol/LCr: 20 - 250 mmol/L</td><td rowspan=1 colspan=1>Serum/Plasma:Na*: SameK*: SameCr: SameUrine:Na*: SameK*: SameCl: 10 - 250 mmol/L</td></tr></table>

# 510(k) Summary - ISE Indirect Na, K, Cl for Gen.2, Continued

The table below indicates the differences between the modified ISE Indirect Na, K, Cl for Gen.2 device and its predicate device (original ISE Na, K, Cl, K953239).

Substantial equivalency - Differences   

<table><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Predicate device: originalISE Na, K, Cl (K953239)</td><td rowspan=1 colspan=1>Modified device: ISE Indirect Na,K, Cl for Gen.2</td></tr><tr><td rowspan=1 colspan=3>Electrode / Reagent information</td></tr><tr><td rowspan=1 colspan=1>ISE DiluentComposition</td><td rowspan=1 colspan=1>650 mmol/L Boric acidPreservative (Gentamicin based)</td><td rowspan=1 colspan=1>10 mmol/L HEPES buffer7 mmol/L TriethanolaminePreservative</td></tr><tr><td rowspan=1 colspan=1>ISE InternalStandardComposition</td><td rowspan=1 colspan=1>650 mmol/L Boric acid32.3 mmol/L Sodium Chloride12.9 mmol/L Sodium bicarbonate1.6 mmol/L Potassium phosphatePreservative (Gentamicin based)</td><td rowspan=1 colspan=1>10 mmol/L HEPES buffer7 mmol/L Triethanolamine3.06 mmol/L Sodium chloride1.45 mmol/L Sodium acetate0.16 mmol/L Potassium chloridePreservative</td></tr><tr><td rowspan=1 colspan=1>Electrode SlopeRanges</td><td rowspan=1 colspan=1>Sodium: 32.0 to 68.0 mV/decadePotassium: 32.0 to 68.0 mV/decadeChloride: -35.0 to -68.0 mV/decade</td><td rowspan=1 colspan=1>Sodium: 50 to 68 mV/decadePotassium: 50 to 68 mV/decadeChloride: -40 to -68 mV/decade</td></tr><tr><td rowspan=1 colspan=1>Calibrator, S3for compensation</td><td rowspan=1 colspan=1>Precical Calibrator Serum</td><td rowspan=1 colspan=1>ISE Compensator (serum based)</td></tr><tr><td rowspan=1 colspan=1>Quality control</td><td rowspan=1 colspan=1>Precitrol-N Control Serum andPrecitrol-A Control Serum or othercommercially available controls</td><td rowspan=1 colspan=1>Precinorm U and Precipath U orother commercially availablecontrols</td></tr><tr><td rowspan=1 colspan=1>ISE CleaningSolution</td><td rowspan=1 colspan=1>4 N NaOH/System CleaningSolution</td><td rowspan=1 colspan=1>ISE Cleaning Solution:Sodium hydroxide, 12% withSodium hypochlorite solution &lt; 2%active Cl(4 N NaOH/System CleaningSolution can also be used)</td></tr><tr><td rowspan=1 colspan=1>Traceability</td><td rowspan=1 colspan=1>NIST reference material</td><td rowspan=1 colspan=1>Flame Photometry, Coulometry withNIST reference material</td></tr><tr><td rowspan=1 colspan=1>Reagent Onboard Stability</td><td rowspan=1 colspan=1>ISE 1N KCl, ISE Diluent workingsolution and ISE Internal Referenceworking solution, stable at 20-25 Cuntil expiration date on bottle label.</td><td rowspan=1 colspan=1>ISE 1N KCl, up to the expirationdateISE Diluent and ISE InternalReference, 6 weeks on board.</td></tr></table>

# 510(k) Summary - ISE Indirect Na, K, CI for Gen.2, Continued

<table><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=4>Predicate device: originalISE Na, K, Cl (K953239)</td><td rowspan=1 colspan=4>Modified device: ISE Indirect Na,K, Cl for Gen.2</td><td></td></tr><tr><td rowspan=1 colspan=9>Labeled performance characteristics</td><td></td></tr><tr><td rowspan=29 colspan=1>Precision</td><td rowspan=1 colspan=4>Total Imprecision, SerumSodium (mmol/L), n=63:</td><td></td><td rowspan=1 colspan=4>Between day Imprecision, PlasmaSodium (mmol/L), n=21:</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>151.6</td><td rowspan=1 colspan=1>128.0</td><td rowspan=1 colspan=1></td><td></td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>143.0</td><td rowspan=1 colspan=1>128.5</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Total SD</td><td rowspan=1 colspan=1>0.89</td><td rowspan=1 colspan=1>0.79</td><td rowspan=1 colspan=1></td><td></td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.51</td><td rowspan=1 colspan=1>0.52</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Total CV</td><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1></td><td></td><td rowspan=1 colspan=1>CV</td><td rowspan=1 colspan=1>0.4%</td><td rowspan=1 colspan=1>0.4%</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=4>Potassium (mmol/L), n=63:</td><td></td><td rowspan=1 colspan=4>Potassium (mmol/L), n=21:</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>6.32</td><td rowspan=1 colspan=1>3.50</td><td rowspan=1 colspan=1></td><td></td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>6.95</td><td rowspan=1 colspan=1>4.27</td><td></td></tr><tr><td rowspan=1 colspan=1>Total SD</td><td rowspan=1 colspan=1>0.05</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1></td><td></td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.01</td><td></td></tr><tr><td rowspan=1 colspan=1>Total CV</td><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1></td><td></td><td rowspan=1 colspan=1>CV</td><td rowspan=1 colspan=1>0.3%</td><td rowspan=1 colspan=1>0.3%</td><td></td></tr><tr><td rowspan=1 colspan=4>Chloride (mmol/L), n-63:</td><td></td><td rowspan=1 colspan=4>Chloride (mmol/L), n=21:</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>120.4</td><td rowspan=1 colspan=1>98.7</td><td rowspan=1 colspan=1></td><td></td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>118.8</td><td rowspan=1 colspan=1>92.7</td><td></td></tr><tr><td rowspan=1 colspan=1>Total SD</td><td rowspan=1 colspan=1>1.39</td><td rowspan=1 colspan=1>0.71</td><td rowspan=1 colspan=1></td><td></td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.42</td><td rowspan=1 colspan=1>0.42</td><td></td></tr><tr><td rowspan=1 colspan=1>Total CV</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>0.7%</td><td rowspan=1 colspan=1></td><td></td><td rowspan=1 colspan=1>CV</td><td rowspan=1 colspan=1>0.4%</td><td rowspan=1 colspan=1>0.5%</td><td></td></tr><tr><td rowspan=1 colspan=4>Total Imprecision, UrineSodium (mmol/L):</td><td></td><td rowspan=1 colspan=4>Between day Imprecision, UrineSodium (mmol/L), n=21:</td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>63</td><td rowspan=1 colspan=1></td><td></td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>23.7</td><td rowspan=1 colspan=1>160.5</td><td></td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>59.4</td><td rowspan=1 colspan=1>163.3</td><td rowspan=1 colspan=1></td><td></td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.77</td><td rowspan=1 colspan=1>0.64</td><td></td></tr><tr><td rowspan=1 colspan=1>Total SD</td><td rowspan=1 colspan=1>0.93</td><td rowspan=1 colspan=1>0.91</td><td rowspan=1 colspan=1></td><td></td><td rowspan=1 colspan=1>CV</td><td rowspan=1 colspan=1>3.3%</td><td rowspan=1 colspan=1>0.4%</td><td></td></tr><tr><td rowspan=1 colspan=1>Total CV</td><td rowspan=1 colspan=1>1.6%</td><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1></td><td></td><td rowspan=2 colspan=4>Potassium (mmol/L), n=21:</td></tr><tr><td rowspan=2 colspan=4>Potassium (mmol/L):</td><td></td></tr><tr><td></td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>19.86</td><td rowspan=1 colspan=1>59.67</td><td></td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>63</td><td rowspan=1 colspan=1></td><td></td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.15</td><td rowspan=1 colspan=1>0.68</td><td></td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>23.58</td><td rowspan=1 colspan=1>52.64</td><td rowspan=1 colspan=1></td><td></td><td rowspan=1 colspan=1>CV</td><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1>1.1%</td><td></td></tr><tr><td rowspan=1 colspan=1>Total SD</td><td rowspan=1 colspan=1>0.22</td><td rowspan=1 colspan=1>0.70</td><td rowspan=1 colspan=1></td><td></td><td rowspan=2 colspan=4>Chloride (mmol/L), n=21:</td></tr><tr><td rowspan=1 colspan=1>Total CV</td><td rowspan=1 colspan=1>0.9%</td><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1></td><td></td></tr><tr><td rowspan=2 colspan=4>Chloride (mmol/L):</td><td></td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>21.4</td><td rowspan=1 colspan=1>154.5</td><td></td></tr><tr><td></td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.51</td><td rowspan=1 colspan=1>1.00</td><td></td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>63</td><td rowspan=1 colspan=1></td><td></td><td rowspan=1 colspan=1>CV</td><td rowspan=1 colspan=1>2.4%</td><td rowspan=1 colspan=1>0.6%</td><td></td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>52.7</td><td rowspan=1 colspan=1>144.7</td><td rowspan=1 colspan=1></td><td></td><td rowspan=3 colspan=4></td></tr><tr><td rowspan=1 colspan=1>Total SD</td><td rowspan=1 colspan=1>0.92</td><td rowspan=1 colspan=1>1.50</td><td rowspan=1 colspan=1></td><td></td></tr><tr><td rowspan=1 colspan=1>Total CV</td><td rowspan=1 colspan=1>1.7%</td><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1></td><td></td></tr></table>

# 510(k) Summary - ISE Indirect Na, K, CI for Gen.2, Continued

<table><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Predicate device: originalISE Na, K, Cl (K953239)</td><td rowspan=1 colspan=1>Modified device: ISE Indirect Na,K, Cl for Gen.2</td></tr><tr><td rowspan=1 colspan=3>Labeled performance characteristics</td></tr><tr><td rowspan=1 colspan=1>Linearity</td><td rowspan=1 colspan=1>Sodium (serum): 59.8199.6mmol/L with deviation of less than2.0 mmol/L or 3%Potassium (serum): 0.52-12..20mmol/L with deviation of less than0.1 mmol/L or 1%Chloride (serum): 43.4-164.5mmol/L with deviation of less than0.4 mmol/L or 1%</td><td rowspan=1 colspan=1>Sodium:Serum = 80-180 mmol/LUrine = 10-250 mmol/LDeviation ± 5% from 40.0-250mmol/L or ± 3 mmol/L atconcentrations &lt; 40.0 mmol/LPotassium:Serum = 1.5-10 mmol/LUrine = 10-100 mmol/LDeviation ± 10 % from 10.0-100.0mmol/L, ± 5% from 1.0-10.0mmol/LChloride:Serum = 60.0-140.0 mmol/LUrine = 10.0 to 250.0 mmol/LDeviation ± 5 % from 45.0-250.0mmol/L, ± 8 mmol/L from &lt; 45.0mmol/L</td></tr></table>

# 510(k) Summary - ISE Indirect Na, K, CI for Gen.2, Continued

<table><tr><td>Feature</td><td>Predicate device: original ISE Na, K, Cl (K953239)</td><td>Modified device: ISE Indirect Na, K, Cl for Gen.2</td></tr><tr><td colspan="3">Labeled performance characteristics Method Sodium (serum), Passing-Bablok:</td></tr><tr><td rowspan="3">Comparison</td><td>x method = Hitachi 717 y method = Hitachi 917 n=99 y= 1.013x - 2.21, r = 0.998</td><td>Sodium (plasma), Passing-Bablok: x method = Hitachi 911 (predicate reagent) y method = Hitachi 917 (modified reagent) n = 58 y= 1.000x - 1.300, r = 0.988</td></tr><tr><td>Potassium (serum), Passing-Bablok: x method = Hitachi 717 y method = Hitachi 917 n=94 y= 0.980x + 0.087, r = 1.000</td><td>Potassium (plasma), Passing-Bablok: x method = Hitachi 911 (predicate reagent) y method = Hitachi 917 (modified reagent) n = 58</td></tr><tr><td>Chloride (serum), Passing-Bablok: x method = Hitachi 717 y method = Hitachi 917 n =99 y= 1.004x + 0.65, r = 0.997</td><td>y= 1.000x - 0.070, r = 0.999 Chloride (plasma), Passing-Bablok: x method = Hitachi 911 (predicate reagent) y method = Hitachi 917 (modified reagent) n = 58</td></tr><tr><td>Endogenous interferences</td><td>Reference Literature</td><td>y= 0.993x - 0.664, r = 0.994 Hemolysis: Sodium and Chloride, no significant interference up to 1000 mg/dL hemoglobin Potassium, hemoglobin &gt;100 mg/dL increase apparent potassium levels significantly Icterus: No significant interference from conjugated and unconjugated bilirubin up to 60 mg/dL</td></tr></table>

# DEC 1 4 2005

Food and Drug Administration 2098 Gaither Road Rockville MD 20850

Mr. Kerwin Kaufman, MBA, MT (ASCP)   
Regulatory Affairs Consultant   
Centralized Diagnostics   
Roche Diagnostics   
9115 Hague Road   
P.O. Box 50416   
Indianapolis, IN 46250

Re: k053165 Trade/Device Name: ISE Indirect Na, K, CI for Gen.2 Regulation Number: 21 CFR 862.1665 Regulation Name: Sodium test system Regulatory Class: Class II Product Code: JGS, CEM, CGZ Dated: November 11, 2005 Received: November 14, 2005

Dear Mr. Kaufman:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA mav publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of thc Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address   
http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

![](images/9647be4a852bfe298b7d678c4eb7505d41b9d3398287026def5db5f767d90d20.jpg)

Alberto Gutierrez, Ph.D.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use

510(k) Number (if known):

Device Name: ISE Indirect Na, K, Cl for Gen.2

Indications For Use:

The ISE module of the Roche / Hitachi systems is intended for the quantitative determination of sodium. notassium. and chloride in serum, plasma, or urine using ion-selective electrodes.

Sodium measurements are used in the diagnosis and treatment of aldosteronism (excessive secretion of the hormone aldosterone), diabetes insipidus (chronic excretion of large amounts of dilute urine, accompanied by extreme thirst), adrenal hypertension, Addison's disease (caused by destruction of the adrenal glands), dehydration, inappropriate antidiuretic hormone secretion, or other diseases involving electrolyte imbalance. Potassium measurements are used to monitor electrolyte balance in the diagnosis and treatment of disease conditions characterized by low or high blood potassium levels. Chloride measurements are used in the diagnosis and treatment of electrolvte and metabolic disorders such as cystic fibrosis and diabetic acidosis.

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/9e237c09159917fdba4605db5fe8c63255e7b2d28d4ced95b299753ee0634f5d.jpg)

Confidential

Dlagnostic t taalon and Salety

Page l of